Professor Michael Levin, Professor Mark Nicol, Professor Heather Zar, Professor Gerhard Walz, Professor Beate Kampmann, Professor Tom Ottenhoff., National Institutes of Health (NIH) Grant (Imperial College London, University of Cape Town, University of Stellenbosch, MRC The Gambia at LSHTM, University of Leiden)., National Institute of Health (NIH) grant consortium - Validation of promising biomarkers for childhood tuberculosis and their development for future use as diagnostic tests., 2016 - 2021
Professor Håvard Jenssen, Roskilde University Denmark, Antimicrobial peptoids, 2016
Rachel Ee Pui Lai, National University of Singapore, 2011
Professor RA Floto, University of Cambridge, Tuberculosisnon tuberculous mycobacteriaAutophagyDrug screening, 2011
Michael Levin (PI), Imperial College London and EUCLIDS consortium, The genetic basis of meningococcal disease and other life threatening bacterial infections of childhood, 2011 - 2016
Paul Langford, Imperial College London, Antimicrobial polymers and nanoparticles, 2011 - 2012
Rachel Ee, Pui LaiNMRC grant, National University of Singapore,A Star University - Singapore, Active targeting of tuberculosis via novel nanotherapeutics, 2011 - 2014
Research Student Supervision
Asai,M, Galleria mellonella: a novel infection model for Mycobacterium tuberculosis aimed at reducing and replacing animals in experimentation
Asai,M, MRes - Evaluation of de novo designed synthetic antimicrobial peptides for inhibitory growth activity of clinically relevant bacterial pathogens
Broderick,C, Ph.D. The role of viral coinfection in the progression of Mycobacterium tuberculosis infection in children
Chang,Y, MSc Development of a human in vitro granuloma model for rapid screening of anti-mycobacterial drugs
Cheyne,A, Ph.D. Applying –omics technology to understand host-pathogen interactions during Mycobacterium tuberculosis infection.
Claire,B, The role of viral coinfection in the progression of Mycobacterium tuberculosis infection
Curio,S, The evaluation of novel synthetic antimicrobial peptides for activity against non-tuberculous mycobacteria
Harris,K, MSc Assessment of a novel anti-mycobacterial agent in an in vitro kinetic model
Khara,JS, Ph.D. De novo design of antimicrobial peptides for application as anti--infective agents
Mansour,E, MSc An in vitro model of human mycobacterial-induced granulomas
Nkamba,HC, MSc Anti-mycobacterial activity and immunological responses of antimicrobial peptides
Sabnis,A, BSc Antimicrobial peptides: a novel therapeutic strategy against non-tuberculous mycobacteria infection?
Vijayakumar,P, BSc The effect of hydroxychloroquine on mycobacterial infection and growth
cheyne,A, Applying –omics technology to understand host-pathogen interactions during Mycobacterium tuberculosis infection using the whole-blood infection assay
von Both,U, ESPID Fellow: Childhood tuberculosis: A new acquired immunodeficiency syndrome.